Glomerular accumulation of extracellular matrix is a prominent feature of progressive glomerulonephritis. Previously, we have shown that transforming growth factor-beta (TGF-beta) is unique among growth factors in regulating the production of the proteoglycans biglycan and decorin by glomerular mesangial cells in vitro. We now provide evidence of an elevated expression of TGF-beta, proteoglycans, and fibronectin in glomerulonephritis induced in rats by injection of anti-thymocyte serum (ATS). Glomeruli were cultured from rat kidneys at 1, 4, 7, 14, and 28 d after ATS administration. Increased proteoglycan synthesis was detected beginning on day 4, which peaked at a 4,900% increase compared with control on day 7, and returned toward control levels by day 28. The increased proteoglycan synthesis by cultured nephritic glomeruli, as well as that of fibronectin, were greatly reduced by addition of antiserum raised against a synthetic peptide from TGF-beta. Conditioned media from ATS glomerular cultures, when added to normal cultured mesangial cells, induced elevated proteoglycan synthesis that also peaked on day 7 and that mimicked the response to added exogenous TGF-beta. The stimulatory activity of the conditioned media was blocked by addition of TGF-beta antiserum. Prior addition of the immunizing peptide to the antiserum abolished the blocking effect. The main induced proteoglycans were identified as biglycan and decorin by immunoprecipitation with antiserum made against synthetic peptides from the proteoglycan core proteins. Glomerular histology showed mesangial matrix expansion in a time course that roughly paralleled both the elevated proteoglycan synthesis by the ATS glomeruli and the ability of the conditioned media from these glomeruli to induce proteoglycan synthesis. At the same time there was an increased expression of TGF-beta mRNA and TGF-beta protein in the glomeruli. These results suggest a central role for TGF-beta in the accumulation of pathological extracellular matrix in glomerulonephritis.
S Okuda, L R Languino, E Ruoslahti, W A Border
Title and authors | Publication | Year |
---|---|---|
Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo
C Daniel, J Wiede, HC Krutzsch, SM Ribeiro, DD Roberts, JE Murphy-Ullrich, C Hugo |
Kidney International | 2004 |
Pathogenesis of Chronic Pancreatitis: An Evidence-Based Review of Past Theories and Recent Developments
T Stevens, DL Conwell, G Zuccaro |
The American Journal of Gastroenterology | 2004 |
Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy
F Sato, I Narita, S Goto, D Kondo, N Saito, J Ajiro, D Saga, A Ogawa, M Kadomura, F Akiyama, Y Kaneko, M Ueno, M Sakatsume, F Gejyo |
Tissue Antigens | 2004 |
Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect
L Yu, WA Border, I Anderson, M McCourt, Y Huang, NA Noble |
Kidney International | 2004 |
Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats
LJ Ma, S Jha, H Ling, A Pozzi, S Ledbetter, AB Fogo |
Kidney International | 2004 |
Protease inhibitors modulate apoptosis in mesangial cells derived from a mouse model of HIVAN1
A Mongia, M Bhaskaran, K Reddy, N Manjappa, N Baqi, PC Singhal |
Kidney International | 2004 |
Cytokines and Wound Healing: The Role of Cytokine and Anticytokine Therapy in the Repair Response
PA Efron, LL Moldawer |
Journal of Burn Care & Rehabilitation | 2004 |
Involvement of stromal proteoglycans in tumour progression
Y Wegrowski, FX Maquart |
Critical Reviews in Oncology/Hematology | 2004 |
Ursolic acid, an antagonist for transforming growth factor (TGF)-β1
S Murakami, H Takashima, M Sato-Watanabe, S Chonan, K Yamamoto, M Saitoh, S Saito, H Yoshimura, K Sugawara, J Yang, N Gao, X Zhang |
FEBS Letters | 2004 |
Sphingosine 1-Phosphate Cross-activates the Smad Signaling Cascade and Mimics Transforming Growth Factor-β-induced Cell Responses
C Xin, S Ren, B Kleuser, S Shabahang, W Eberhardt, H Radeke, M Schäfer-Korting, J Pfeilschifter, A Huwiler |
The Journal of biological chemistry | 2004 |
The Role of Epithelial to Mesenchymal Transdifferentiation in End-Stage Renal Disease
R Sam |
The International Journal of Artificial Organs | 2004 |
Transforming growth factor-?1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors
AM Wasilewska, WM Zoch-Zwierz |
Pediatric Nephrology | 2004 |
Urinary transforming growth factor-β1 in various types of nephropathy
PD Muro, R Faedda, P Fresu, A Masala, A Cigni, G Concas, MG Mela, A Satta, A Carcassi, GM Sanna, GM Cherchi |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2004 |
Age-related differences in Adriamycin-induced nephropathy
H Hahn, YS Park, IS Ha, HI Cheong, Y Choi |
Pediatric Nephrology | 2004 |